| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | — | -43.4% |
| Cost of Revenue | $975K | — | -46.5% |
| Gross Profit | $237K | — | -26.2% |
| R&D Expense | $478K | — | -39.0% |
| SG&A Expense | $3.4M | — | -30.9% |
| Operating Income | -$4.0M | — | +35.5% |
| Pre-tax Income | -$4.1M | — | +24.2% |
| Income Tax | -$13K | — | -11.1% |
| Net Income | -$3.9M | — | +30.9% |
| EPS (Basic) | -$2.66 | — | -1377.8% |
| EPS (Diluted) | -$2.66 | — | -1377.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.6M | -19.4% | -57.7% |
| Accounts Receivable | $1.2M | -7.6% | -61.8% |
| Inventory | $22.0M | +0.2% | -13.0% |
| Current Assets | $45.0M | -1.5% | -28.6% |
| Total Assets | $73.3M | -1.6% | -43.4% |
| Current Liabilities | $26.6M | -0.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | +43.4% |
| Capital Expenditures | $4K | — | -99.3% |
| Investing Cash Flow | $111K | — | +122.3% |
| Financing Cash Flow | $1.7M | — | +44.2% |
| Free Cash Flow | -$2.8M | — | +48.7% |
| -14.3% |
| Long-term Debt | $3.0M | +150.5% | +796.4% |
| Total Liabilities | $35.6M | +4.6% | -36.3% |
| Stockholders' Equity | $37.5M | -6.8% | -48.8% |